ONC201/TIC10 is a novel small molecule inducer of the human TRAIL gene that improves efficacy-limiting properties of recombinant TRAIL and is in clinical trials in advanced cancers based on its promising safety and antitumor efficacy in several preclinical models. ONC201/TIC10 can cross the blood-brain barrier.
武汉永璨生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
武汉永璨生物